A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer
NCT04118933
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
JS001
Sponsor
Xu jianmin